Diiron enneacarbonyl, colloidal iron particles used for removing monocytes, enhanced the 3H-thymidine uptake into the mitogen-stimulated human lymphocytes in serum-free medium, whereas neither silica particles, latex particles, carbonyl iron powder nor iron pentacarbonyl did. Because monocytes had no influence on the enhancing effect or diiron enneacarbonyl did not bind to PHA, it was suggested that the enhancing effect was performed by diiron enneacarbonyl directly acting on the mitogen-activated lymphocytes in serum-free medium.
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Carbonyl iron treatment is a commonly used technique to remove phagocytic cells during the separation of lymphocytes (Lundgren et al. 1968; Tebbi 1973; Lohrmann et al. 1974; Abo et al. 1976 ). Although several investigators have observed the influence of carbonyl iron treatment on the lymphocyte subpopulations (Sanderson et al. 1975; Fernandez and MacSween 1977; Rumpold et al. 1979) , there has been no report on its effect on the lymphocyte activities.
In the course of our study on the effects of monocytes on the lymphocyte transformation and lymphokine production in serum-free medium, we observed that diiron enneacarbonyl (Fe2(CO)9, also known as iron nonacarbonyl), colloidal carbonyl iron particles used for removing monocytes (Tebbi 1973; Abo et al. 1976 ), enhanced the 3H-thymidine uptake into the mitogen-stimulated lymphocytes. We report here that diiron enneacarbonyl directly exerts the enhancing effect on the lymphocyte transformation induced by mitogen in serum-free medium supplemented with bovine serum albumin (BSA).
MATERIALS AND METHODS
Medium. In addition to 0.5% BSA (Sigma Chemical Co., St. Louis, Mo.), Eagle's minimum essential medium (MEM) was supplemented with sodium pyruvate, insulin, putrescine, zinc sulfate and various nucleosides, as described previously (Yamane et al. 1976; Arai et al. 1977) . RPMI 1640 with 10% heat-inactivated fetal calf serum (FCS; Grand Island Biological Co., Grand Island, N.Y.) was used as serum containing medium.
Cell preparation. Mononuclear leucocytes were separated from heparinized venous peripheral blood of normal volunteers by centrifugation on Ficoll-Isopaque gradient, washed three times and adjusted to 5 x 105 cells/ml in the culture medium.
Depletion of monocytes from peripheral blood lymphocytes (PBL) was performed either by phagocytosis method or adherence method. The phagocytosis method was done by incubating whole blood either with 5% diiron enneacarbonyl (Abo et al. 1976) or 5% silica particles for 1 hr at 37°C on a rocker and centrifuging on Ficoll-Isopaque. In the adherence method, PBL were incubated on the plastic dish (3001; Falcon Labware, Oxnard, Calif.) for 1 hr at 37°C and then non-adherent cells were isolated. Monocytes were identified by peroxidase staining. T cell enriched fraction was obtained by separating lymphocytes rosetting with neuraminidase-treated sheep red blood cells (SRBC) from non-rosetting cells. SRBC were lyzed by 0.01 M Tris 0.83% ammonium chloride.
Cell culture and DNA assay. Cells were cultured with or without mitogen in tissue culture microplates (3040; Falcon Labware). Each well containing 0.2 ml of culture medium with 1>< 105 cells was incubated at 37°C in an atmosphere of 5% CO2 and 95% air.
3H-thymidine (0.8 yCi/well; New England Nuclear Inc., Boston, Mass.; specific activity, 10 Ci/mmole) was added to the culture 4 hr prior to termination of the incubation. After labeling, cells were harvested onto glass fiber filters with a multiple sample harvester, and their radioactivity was counted by a liquid scintillation counter. All cultures were performed in triplicate, and results were expressed as mean counts per min for triplicate determinations.
Reagents. Phytohemagglutinine-P (PHA; Difco Laboratories, Detroit, Mich.), concanavalin A (ConA; Miles-Veda, Ltd., Israel), pokeweed mitogen (PWM; Grand Island Biological Co.), Sepharose-ConA (Pharmacia, Uppsala, Sweden) and Staphylococcus protein A (Pharmacia) were diluted with the medium to an appropriate concentration.
Diiron enneacarbonyl and silica particles which were purchased from Japan Immunoresearch Laboratories Co., Ltd. (Takasaki), iron pentacarbonyl (Strem Chemicals, Inc., Danvers, Mass.), carbonyl iron powder (Nakarai Chemicals, Tokyo) and polystylen latex particles (diameter 0.7 µm, Takeda Chemical Indust., Osaka) were suspended in the medium.
RESULTS
Effects of various substances on the blastogenesis of lymphocytes. As shown in Fig. 1 , addition of diiron enneacarbonyl to the culture enhanced PHA-stimulated transformation of the PBL. Such effect was not seen in culture with silica particles, carbonyl iron powder and polystylen latex particles (which are used for phagocytosis of macrophages) or iron pentacarbonyl from which diiron enneacarbonyl is formed by ultraviolet irradiation (Braye and Ubel 1966) .
The supernatant fluid of diiron enneacarbonyl suspension which was passed through Millipore filter (0.05 ,um) had no enhancing effect, either.
Kinetics of PHA stimulation of lymphocytes in serum free medium with diiron enneacarbonyl. Lymphocyte transformations by different concentrations of PHA in serum-free medium supplemented with optimal dose of diiron enneacarbonyl during a period of 168 hr are shown in Fig. 2 . DNA synthesis began at 48-72 hr and reached its maximum after 96 hr of incubation. The higher levels of DNA synthesis were observed in the range of PHA concentrations, 1.9-7.5 ,ug/ml.
To see on what stage of the PHA-stimulated lymphocyte culture diiron enneacarbonyl exerts its enhancing effect, the compound was added to the culture at varying times of the incubation.
As shown in Fig. 3 , the enhancing effects were found when it was added within 24 hr except for one case, although it should be noted that the constant fall of 311-thymidine uptake was seen when added 6 hr after the culture . It was suggested that the cells at 6 hr after PHA stimulation partially became refractory to the action of diiron enneacarbonyl. Anyway these results indicated that this compound acts on early events in the activation of lymphocytes.
Influence o f monocytes on the enhancing effect o f diiron enneacarbonyl. In order to examine the possibility that the enhancing effect could be mediated by factor(s) released from monocytes which phagocytosed diiron enneacarbonyl, various monocyte-depleted PBL or T cell enriched fractions were tested. As shown in Table 1 , irrespective of the concentrations of monocytes, the enhancing effects of diiron enneacarbonyl were found. Therefore, it is clear that monocytes have no influence on the enhancing effects of diiron enneacarbonyl. Fig. 2 . Kinetics of PHA stimulation of human peripheral lymphocytes (5 x 105/ml) in serum-free medium containing diiron enneacarbonyl (0.5 ,pg/ml) with varying concentrations of PHA; 15 pg/ml (a), 7.5 pg/ml (.), 3.8 pg/ml (o), 1.9 pg/ml (.), 0.9 pg/ml (o) or 0 pg/ml (x).
Shaded area represents the levels of 3H-thymidine uptake without diiron enneacarbonyl. 3 . Kinetics of the enhancing effect of diiron enneacarbonyl on the PHA stimulation, Diiron enneacarbonyl (0.5 yg/ml) was added to the culture at varying times of the incubation of PHA-stimulated lymphocytes from five individuals. Cells (5 X 106/ml) were incubated for 96 hr with PHA (7.5 yg/ml). Binding of PHA to diiron enneacarbonyl. To see whether or not diiron enneacarbonyl exerts its enhancing effect by means of binding to PHA, diiron enneacarbonyl was incubated with PHA for 1 hr, washed three times and added to the culture medium. The 3H-thymidine uptake was 2,574±328 cpm when PHAtreated diiron enneacarbonyl was added to the culture of lymphocytes without mitogen, whereas that value was 80,194±6,124 cpm when both PHA treated diiron enneacarbonyl and PHA (7.5 µg/ml) were added. These results indicate that diiron enneacarbonyl does not bind to PHA.
Enhancing effects in the case of other mitogens. As shown in Table 2 , the enhancing effects of diiron enneacarbonyl on the lymphocyte transformation were observed with all mitogens examined.
Comparison o f the effects o f diiron enneacarbonyl in serum free medium and in serum-containing medium. The enhancing effects were seen in all cases with serumfree medium, while in serum-containing medium diiron enneacarbonyl rather suppressed the 3H-thymidine uptake into the PHA-stimulated lymphocytes as shown in Table 3 . Y. Tanno and T. Takishima
DISCUSSION
The experiments described here demonstrate that diiron enneacarbonyl enhances thymidine incorporation into mitogen-stimulated lymphocytes in a serum-free culture system. To our knowledge, the study on the activity of diiron enneacarbonyl on human lymphocytes has never been reported.
Diiron enneacarbonyl is obtained as shiny orange hexagonal crystals by exposing iron pnneacarbonyl to ultraviolet rays (Braye and Ubel 1966) , having a density of 2.08 g/cc with diamagnetic property and insoluble in any organic solvent (Powell and Ewens 1939) . This compound has been used for depleting monocytes from mononuclear leucocytes with a high degree of efficiency (Tebbi 1973; Abo et al. 1976 ).
Several investigators have so far reported on the insoluble substances that augmented blast transformation of lymphocytes. Thus, human red blood cells (Tarnvik 1970; Johnson et al. 1972; Yachnin 1972; Yachnin et al. 1972 ), their membranes (Johnson et al. 1972; Yachnin et al. 1972) , leucocytes (Tarnvik 1970) and platelets (Yachnin 1972; Yachnin et al. 1972) From our results, this hypothesis does not seem to provide an explanation for the enhancing effect of diiron enneacarbonyl since it does not significantly bind to PHA.
As another explanation for the enhancing effect of diiron enneacarbonyl, the possibility exists for the release of iron from this substance which may bind to the lymphocytes. Such iron transport from Sepharose-bound transferrin as described previously (Glass et al. 1977 ) has been considered. Diiron enneacarbonyl could be an available source of iron which has been demonstrated to play an essential role in DNA synthesis of mitogen-stimulated lymphocytes (Hoffbrand et al. 1976) .
Although an exact mechanism whereby diiron enneacarbonyl augments thymidine uptake into mitogen-stimulated lymphocytes in serum-free medium remains to be elucidated, it is important to bear in mind that diiron enneacarbonyl has an influence on the activities of lymphocytes when this compound is used for removing phagocytic cells. Cell Structure and Function, 1, 279-284.
